The largest purchase of all time was on 2020-03-03 and amounted to 450000 shares of Passage Bio, Inc. for $8.1M.
The largest sale of all time was on 2018-04-26 and amounted to 421220 shares of CRISPR Therapeutics AG for $21.11M.
No biography is available at this moment.
| 2022-04-29 | Tempest Therapeutics, Inc. TPST | 2.12M 11.9674% | $2.36 | $5M | -44.6% | |||
| 2020-10-20 | Aligos Therapeutics, Inc. ALGS | director | 200,000 0.7223% | $15.00 | $3M | +61.44% | ||
| 2020-03-03 | Passage Bio, Inc. PASG | 450,000 2.298% | $18.00 | $8.1M | -5.13% | |||
| 2018-05-15 | Sale | CRISPR Therapeutics AG CRSP | director | 88,000 0.1886% | $57.99 | $5.1M | -33.02% | |
| 2018-05-08 | Sale | CRISPR Therapeutics AG CRSP | director | 3,306 0.007% | $51.45 | $170,094 | -25.3% | |
| 2018-05-07 | Sale | CRISPR Therapeutics AG CRSP | director | 239,418 0.4979% | $50.38 | $12.06M | -24.94% | |
| 2018-04-30 | Sale | CRISPR Therapeutics AG CRSP | director | 61,132 0.1401% | $50.29 | $3.07M | -17.16% | |
| 2018-04-27 | Sale | CRISPR Therapeutics AG CRSP | director | 23,296 0.0509% | $50.02 | $1.17M | -20.73% | |
| 2018-04-26 | Sale | CRISPR Therapeutics AG CRSP | director | 421,220 0.9% | $50.11 | $21.11M | -22.47% | |
| 2018-04-24 | Sale | CRISPR Therapeutics AG CRSP | director | 45,682 0.1052% | $50.99 | $2.33M | -17.88% | |
| 2018-04-23 | Sale | CRISPR Therapeutics AG CRSP | director | 203,988 0.4449% | $50.68 | $10.34M | -21.67% | |
| 2017-12-22 | Sale | CRISPR Therapeutics AG CRSP | director | 6,118 0.0147% | $20.29 | $124,141 | +124.44% | |
| 2017-11-27 | Sale | CRISPR Therapeutics AG CRSP | director | 400 0.001% | $20.24 | $8,096 | +142.15% | |
| 2017-11-24 | Sale | CRISPR Therapeutics AG CRSP | director | 3,400 0.0086% | $20.21 | $68,716 | +136.81% | |
| 2016-10-24 | CRISPR Therapeutics AG CRSP | director | 322,000 2.6251% | $14.00 | $4.51M | +31.44% |